Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Treatment patterns and cost in advanced stage cervical cancer
From the Ramsey Group, Public Health Sciences Division
Medical tourism and cervical cancer screening among immigrant women
From the Ko Group, Public Health Sciences Division
Fred Hutch team receives $7.5M NCI grant to improve cancer screening
PROSPR II consortium aims to refine detection of cervical, colorectal and lung cancers
Good News: Global Oncology wins NCI grant; 1100 Eastlake building honored; Bish Paul essay in Science; Dr. Joseph Unger leads finasteride study
Celebrating faculty and staff achievements
HPV vaccine uptake highest in Hispanic, low-income communities
Where you live matters for cancer-preventing shot, new study suggests
More early cervical cancer cases being detected under Affordable Care Act
New study finds higher rates of young women covered by parents' private insurance being diagnosed, treated earlier
HPV vaccine: It’s not about sex, it’s about cancer
New, large study shows HPV vaccine does not increase sexual behavior in teen girls
Should HPV test replace the Pap for cervical cancer screening?
A panel of experts offers interim guidance – but main message is get screened and vaccinated
1 in 10 women is not being screened for cervical cancer
As with the HPV vaccine, a key barrier is 'missed opportunities' among doctors
Too much screening? Patients with limited life expectancy still getting cancer tests
Overscreening offers little benefit, potential harm and high costs, new studies conclude
An end to routine pelvic exams? Not so fast, some say
Cutting through the confusion on conflicting guidelines
Test for virus that causes cervical cancer should replace Pap, FDA advisors say
FDA committee advises replacing Pap with DNA test for human papillomavirus